Cheng Andrew

CIK: 0001778307President and CEO
OfficerDirector

Cheng Andrew is a corporate insider (President and CEO) at Akero Therapeutics, Inc. (AKRO) filing SEC Form 4 transactions. 238 transactions across 3 companies, totaling $0 in purchases and $43,390,011 in sales. Source: SEC EDGAR.

Total Transactions
238
Total Buy Value
$0
Total Sell Value
$43.39M
Net Activity
$-43.39M
Last Transaction
Dec 2025
Companies
3

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Award
Shares
17,084
Price
$34.35
Value
$587K
Type
Disposition
Shares
10,000
Price
-
Value
-
Type
Disposition
Shares
234,000
Price
-
Value
-
Type
Disposition
Shares
238,973
Price
-
Value
-
Type
Disposition
Shares
87,220
Price
-
Value
-
Type
Disposition
Shares
165,289
Price
-
Value
-
Type
Disposition
Shares
23,809
Price
-
Value
-
Type
Disposition
Shares
233,252
Price
-
Value
-
Type
Disposition
Shares
374,985
Price
-
Value
-
Type
Disposition
Shares
292,179
Price
-
Value
-
Type
Disposition
Shares
3,527
Price
-
Value
-
Type
Disposition
Shares
4,739
Price
-
Value
-
Type
Disposition
Shares
2,328
Price
-
Value
-
Type
Disposition
Shares
5,032
Price
-
Value
-
Type
Disposition
Shares
3,421
Price
-
Value
-
Type
Disposition
Shares
159,762
Price
-
Value
-
Type
Disposition
Shares
277,075
Price
-
Value
-
Type
Gift
Shares
74,538
Price
-
Value
-
Type
Gift
Shares
14,739
Price
-
Value
-
Type
Exercise
Shares
30,000
Price
-
Value
-